Literature DB >> 14597971

Thrombin generation in severe haemophilia A and B: the endogenous thrombin potential in platelet-rich plasma.

Thomas Siegemund1, Sirak Petros, Annelie Siegemund, Ute Scholz, Lothar Engelmann.   

Abstract

Thrombin generation was investigated in platelet-rich plasma (PRP) from 11 healthy controls, 17 patients with severe haemophilia A and 7 patients with severe haemophilia B. Mean endogenous thrombin potential (ETP) in arbitrary fluorescence units (FU) was 226.9 +/- 44.6, 186.4 +/- 22.5, 154.2 +/- 41.3 in controls, haemophilia A and B, respectively, all at a platelet count of 200 x 10(9)/l (p = 0.004 for controls vs. haemophilia A, p = 0.003 for controls vs. haemophilia B, no significant difference between haemophilia A and B). The contribution of FVIII to thrombin generation in haemophilia A was 1.31 +/- 0.16 FU/% of FVIII:C activity, while for FIX in haemophilia B this was 0.80 +/- 0.21 FU/% of FIX activity. There was an almost linear relationship between increasing platelet count and thrombin generation up to a mean platelet count of 100 x 10(9)/l. Further increase in platelet count has only a marginal influence on thrombin generation. Platelets increase ETP in haemophilia A by 0.184 +/- 0.022 FU/10(9) platelets/l and in haemophilia B by 0.319 +/- 0.085 FU/10(9) platelets/l, and this was significantly different between the two groups (p = 0.0002). This influence of plate-lets diminishes with increasing concentration of either FVIII or FIX. In conclusion, there is a difference in thrombin generation between haemophilia A and B, and this may be attributed to the role of platelets in the assembly of the tenase complex on their surface.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14597971     DOI: 10.1160/TH03-01-0027

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  10 in total

1.  Rare coagulation disorders: an emerging issue.

Authors:  Flora Peyvandi
Journal:  Blood Transfus       Date:  2007-11       Impact factor: 3.443

2.  Coagulation factor XII genetic variation, ex vivo thrombin generation, and stroke risk in the elderly: results from the Cardiovascular Health Study.

Authors:  N C Olson; S Butenas; L A Lange; E M Lange; M Cushman; N S Jenny; J Walston; J C Souto; J M Soria; G Chauhan; S Debette; W T Longstreth; S Seshadri; A P Reiner; R P Tracy
Journal:  J Thromb Haemost       Date:  2015-09-14       Impact factor: 5.824

3.  A modified thrombin generation test for investigating very low levels of factor VIII activity in hemophilia A.

Authors:  Tomoko Matsumoto; Keiji Nogami; Kenichi Ogiwara; Midori Shima
Journal:  Int J Hematol       Date:  2009-11-25       Impact factor: 2.490

4.  Thrombin generation in Cushing's Syndrome: do the conventional clotting indices tell the whole truth?

Authors:  S Koutroumpi; L Spiezia; N Albiger; M Barbot; M Bon; S Maggiolo; S Gavasso; P Simioni; A Frigo; F Mantero; C Scaroni
Journal:  Pituitary       Date:  2014-02       Impact factor: 4.107

5.  ST Genesia reference values of 117 healthy donors measured with STG-BleedScreen, STG-DrugScreen and STG-ThromboScreen reagents.

Authors:  Marisa Ninivaggi; Romy M W de Laat-Kremers; Audrey Carlo; Bas de Laat
Journal:  Res Pract Thromb Haemost       Date:  2020-12-19

6.  Prevalence of non-Alcoholic Fatty Liver Disease and Associated Factors in Patients with Moderate or Severe Hemophilia: A Multicenter-Based Study.

Authors:  Ming-Ching Shen; Shyh-Shin Chiou; Sheng-Chieh Chou; Te-Fu Weng; Ching-Yeh Lin; Jiaan-Der Wang; Shou-Wu Lee; Ching-Tien Peng
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 3.512

7.  From principle to practice: bridging the gap in patient profiling.

Authors:  Jonathan H Foley; Thomas Orfeo; Anetta Undas; Kelley C McLean; Ira M Bernstein; Georges-Etienne Rivard; Kenneth G Mann; Stephen J Everse; Kathleen E Brummel-Ziedins
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

8.  Antiplatelet agents can promote two-peaked thrombin generation in platelet rich plasma: mechanism and possible applications.

Authors:  Ivan D Tarandovskiy; Elena O Artemenko; Mikhail A Panteleev; Elena I Sinauridze; Fazoil I Ataullakhanov
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

Review 9.  Clinical Applications, Pitfalls, and Uncertainties of Thrombin Generation in the Presence of Platelets.

Authors:  Marina Panova-Noeva; Paola E J van der Meijden; Hugo Ten Cate
Journal:  J Clin Med       Date:  2019-12-30       Impact factor: 4.241

Review 10.  The role of the calibrated automated thrombogram in neonates: describing mechanisms of neonatal haemostasis and evaluating haemostatic drugs.

Authors:  Claire A Murphy; Elaine Neary; Daniel P O'Reilly; Sarah Cullivan; Afif El-Khuffash; Fionnuala NíAinle; Patricia B Maguire; Naomi McCallion; Barry Kevane
Journal:  Eur J Pediatr       Date:  2021-07-20       Impact factor: 3.183

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.